Symptom control in patients with hay fever in UK general practice: how well are we doing and is there a need for allergen immunotherapy?-Reference-Cited by-同舟云学术

Symptom control in patients with hay fever in UK general practice: how well are we doing and is there a need for allergen immunotherapy?

Published:1998-03 Issue:3 Volume:28 Page:266-270
ISSN:0954-7894
Container-title:Clinical & Experimental Allergy
language:en
Short-container-title:Clinical & Experimental Allergy

Author:

White ¹,Smith ²,Baker ²,Davis ¹,Frew ³

Affiliation:

1. General Practitioner, Nightingale Surgery, Romsey,,

2. Wessex Primary Care Research Network, Primary Medical Care, University of Southampton,

3. University Medicine, University of Southampton, UK

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2222.1998.00237.x

Reference12 articles.

1. 1 Office of National Statistics. cited in Lung Asthma Information Agency factsheet; 96/:3. Dept of Public Health Sciences, St Georges Hospital Medical School, London.

2. Changes in asthma prevalence: two surveys 15 years apart.

3. Respiratory symptoms and atopy in Aberdeen schoolchildren: evidence from two surveys 25 years apart.

4. Asthma's changing prevalence.

5. Fortnightly review: seasonal allergic rhinitis

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Main Airborne Pollen Species and Characteristics of Allergic Rhinitis Patients with Pollen-Related Allergies in 13 Northern Chinese Cities;Journal of Asthma and Allergy;2024-08

2. Current challenges with adherence to pharmacotherapy in allergic rhinitis;Expert Opinion on Pharmacotherapy;2024-03-03

3. Efficacy and safety of stapokibart (CM310) in uncontrolled seasonal allergic rhinitis (MERAK): an investigator-initiated, placebo-controlled, randomised, double-blind, phase 2 trial;eClinicalMedicine;2024-03

4. The pharmacotherapeutic management of allergic rhinitis in people with asthma;Expert Opinion on Pharmacotherapy;2024-01-02

5. Unified Airway Disease;Otolaryngologic Clinics of North America;2023-02